Call Options Transactions Made in Q4 2022 in Brainstorm Cell Therapeutics Inc. (BCLI)
This table provides information about the institutional ownership of Brainstorm Cell Therapeutics Inc. (BCLI) during Q4 2022. The information is specifically focused on institutions that hold call options of BRAINSTORM CELL THERAPEUTICS INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2023
Q4 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
CALL |
18.6K+ 16.82% |
$25.5K - $82.2K
|
129K
$140K
|
|
|
Feb 14, 2023
Q4 2022
|
Hap Trading, LLC
New York, NY |
BUY
|
CALL |
10.4KNew |
$14.2K - $46K
|
10.4K
$11.2K
|
|
|
Jan 09, 2023
Q4 2022
|
Weaver Consulting Group
|
SELL
|
CALL |
-16.5K- 23.57% |
$22.6K - $72.9K
|
53.5K
$57.8K
|
|
|
Feb 14, 2023
Q4 2022
|
Wolverine Trading, LLC
Chicago, IL |
SELL
|
CALL |
-29.6K- 50.77% |
$40.6K - $131K
|
28.7K
$31K
|
|
|
Feb 14, 2023
Q4 2022
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
CALL |
-282K- 74.09% |
$386K - $1.24M
|
98.5K
$106K
|